CDKN2A Deletion in Melanoma Excludes T Cell Infiltration by Repressing Chemokine Expression in a Cell Cycle-Dependent Manner
T-cell-mediated immune response is the prerequisite for T-cell-based immunotherapy. However, the limitation of T-cell infiltration in solid tumors restricted the therapeutic effect of T-cell-based immunotherapy. The present study screened the molecular and genetic features of The Cancer Genome Atlas...
Main Authors: | Zhen Zhu, Hao Song, Juan Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.641077/full |
Similar Items
-
Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
by: Nicolas Jacquelot, et al.
Published: (2018-10-01) -
Ezh2 Regulates Activation-Induced CD8+ T Cell Cycle Progression via Repressing Cdkn2a and Cdkn1c Expression
by: Guobing Chen, et al.
Published: (2018-03-01) -
Chemokines and chemokine receptors in Behçet’s disease
by: Zhan Li, et al.
Published: (2023-01-01) -
Global pannexin 1 deletion increases tumor‐infiltrating lymphocytes in the BRAF/Pten mouse melanoma model
by: Rafael E. Sanchez‐Pupo, et al.
Published: (2024-04-01) -
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
by: E. Genescà, et al.
Published: (2018-07-01)